CN106214718A - A kind of moxa-moxibustion cream and its preparation method and application - Google Patents
A kind of moxa-moxibustion cream and its preparation method and application Download PDFInfo
- Publication number
- CN106214718A CN106214718A CN201610708042.XA CN201610708042A CN106214718A CN 106214718 A CN106214718 A CN 106214718A CN 201610708042 A CN201610708042 A CN 201610708042A CN 106214718 A CN106214718 A CN 106214718A
- Authority
- CN
- China
- Prior art keywords
- folium artemisiae
- artemisiae argyi
- moxa
- moxibustion cream
- moxibustion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006071 cream Substances 0.000 title claims abstract description 56
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 239000003814 drug Substances 0.000 claims abstract description 17
- 239000000463 material Substances 0.000 claims abstract description 16
- 201000010099 disease Diseases 0.000 claims abstract description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 11
- 201000008482 osteoarthritis Diseases 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 30
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 20
- 241000256846 Apis cerana Species 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 229920000742 Cotton Polymers 0.000 claims description 6
- 241000628997 Flos Species 0.000 claims description 6
- 239000012467 final product Substances 0.000 claims description 6
- 238000011282 treatment Methods 0.000 claims description 5
- 229940099259 vaseline Drugs 0.000 claims description 5
- 235000010894 Artemisia argyi Nutrition 0.000 claims description 4
- 244000030166 artemisia Species 0.000 claims description 4
- 210000002784 stomach Anatomy 0.000 claims description 4
- 206010034464 Periarthritis Diseases 0.000 claims description 3
- 206010041591 Spinal osteoarthritis Diseases 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 208000036319 cervical spondylosis Diseases 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 238000000465 moulding Methods 0.000 claims description 3
- 208000005801 spondylosis Diseases 0.000 claims description 3
- 208000011580 syndromic disease Diseases 0.000 claims description 3
- 238000002560 therapeutic procedure Methods 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 230000000680 avirulence Effects 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 11
- 239000000047 product Substances 0.000 description 9
- 210000002966 serum Anatomy 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 238000001467 acupuncture Methods 0.000 description 4
- 239000011505 plaster Substances 0.000 description 4
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 3
- 235000017491 Bambusa tulda Nutrition 0.000 description 3
- 241001330002 Bambuseae Species 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 3
- 208000012287 Prolapse Diseases 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 239000011425 bamboo Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002893 slag Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000000528 statistical test Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- 208000018650 Intervertebral disc disease Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000007766 cera flava Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 208000021600 intervertebral disc degenerative disease Diseases 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to the traditional Chinese medical science and relevant medicine field, in particular to a kind of moxa-moxibustion cream and its preparation method and application.By weight, described moxa-moxibustion cream is mainly made up of following material component: Folium Artemisiae Argyi 80～120 parts and Folium Artemisiae Argyi 2～5.5 parts.This moxa-moxibustion cream, as external used medicine, can be used for treating arthrosis and cold-evil caused a disease.Avirulence, has no side effect, and will not develop immunity to drugs, abundant raw material source, and production cost is low, and need not medical knowledge and the Therapeutic Method of complexity and can use, and can be described as the standing medicine of family, also can solve the situation of outlying district shortage of medical services and medicines.
Description
Technical field
The present invention relates to the traditional Chinese medical science and relevant medicine field, in particular to a kind of moxa-moxibustion cream and preparation method thereof and should
With.
Background technology
Moxa-moxibustion is the moxibustion therapy in Chinese medicine acupuncture therapy.Point uses moxa cone that Folium Artemisiae Argyi makes, moxa roll is main, the cave of the human body that fire-cures
Position is to reach a kind of naturopathy of promoting health and curing diseases.China in ancient times, Folium Artemisiae Argyi has been important people's livelihood plant the most.It is generally used for pin
" moxibustion " of moxibustion.So-called acupuncture is divided into two parts in fact." pin " is exactly to take acupuncture acupoint, and " moxibustion " is exactly to take Folium Artemisiae Argyi to light it
After go to smoke, scald acupoint, acupoint is heated no doubt stimulation, but is not any paper or grass has been lighted and can have been used as " moxibustion ".Chinese mugwort
The abnormal smells from the patient of grass has played certain effect certainly the most simultaneously.When the method for folks of china cupping treats rheumatism, with Folium Artemisiae Argyi
As fuel effect more preferably.
Moxibustion therapy is in the history of the existing two thousand years of China, and its therapeutic effect is confirmed by countless clinical practices.And to it
The understanding of mechanism, is still a fan not solved.At present, in the prior art, moxa-moxibustion still uses conventional methods and carries out, i.e. people
Body Different Acupoint is lighted Folium Artemisiae Argyi and is realized moxa-moxibustion effect, but this mode operates inconvenience, and effective ingredient contained in Folium Artemisiae Argyi
Can not be absorbed by the body fully, and then make moxa-moxibustion effect less notable, therefore provide that a kind of process is processed, effectively become
Dividing rich content and moxibustion product safe and convenient to use is that current this area has a to be solved technical problem.
In view of this, the special proposition present invention.
Summary of the invention
It is an object of the invention to provide a kind of moxa-moxibustion cream, to solve the problems referred to above.
A kind of moxa-moxibustion cream, weight portion meter, mainly it is made up of following material component:
Folium Artemisiae Argyi 80～120 parts and Folium Artemisiae Argyi 2～5.5 parts.
The moxa-moxibustion cream that the present invention provides can individually be incubated in affected part, or coordinates other plaster to be simultaneously used for treating relevant disease,
And with moxa-moxibustion fiting effect more preferably.
Fresh Folium Artemisiae Argyi juice remains the active ingredient of Oleum Folium Artemisiae Argyi, more maintains the toil of Folium Artemisiae Argyi, and more easy entry spleen
Liver and kidney warp.The soft woolliness of Folium Artemisiae Argyi can fully absorb the active ingredient of storage Oleum Folium Artemisiae Argyi, and can make moxa-moxibustion cream Reusability.
Optionally, moxa-moxibustion cream as above, the preparation method of described Folium Artemisiae Argyi is:
Floss cotton like is crumpled into, through patting to journey thin short flannel shape and get final product after being dried by the fresh Folium Artemisiae Argyi eliminating stem.
Optionally, moxa-moxibustion cream as above, by weight, its material component also includes Apis cerana Fabricius 2～3 parts.
Optionally, moxa-moxibustion cream as above, by weight, its material component also include glycerol or vaseline 0.02～
0.06 part.
Optionally, moxa-moxibustion cream as above, by weight, its material component also includes Oleum menthae 0.04～0.15
Part.
The preparation method of moxa-moxibustion cream as above, comprises the following steps:
Fresh Folium Artemisiae Argyi is obtained Folium Artemisiae Argyi concentrated juice and Folium Artemisiae Argyi and other raw materials in addition to Folium Artemisiae Argyi and Folium Artemisiae Argyi through decocting, boiling
Component mixes, after cooling molding and get final product.
Optionally, preparation method as above, when fresh Folium Artemisiae Argyi is decocted, described fresh Folium Artemisiae Argyi and added water
Weight ratio be 1:(1～3).
Optionally, preparation method as above, the weight of described Folium Artemisiae Argyi concentrated juice is described fresh Folium Artemisiae Argyi weight
20%～30%.
The moxa-moxibustion cream as above application in the medicine for external use that preparation treatment arthrosis and cold-evil are caused a disease.
Optionally, applying as above, described arthrosis includes cervical spondylosis, scapulohumeral periarthritis, prolapse of lumbar intervertebral disc；
Described cold-evil is caused a disease and is included cold womb, cold syndrome of the stomach.
Detailed description of the invention
Below in conjunction with embodiment, embodiment of the present invention are described in detail, but those skilled in the art will
Understanding, the following example is merely to illustrate the present invention, and is not construed as limiting the scope of the present invention.In embodiment unreceipted specifically
Condition person, the condition advised according to normal condition or manufacturer is carried out.Agents useful for same or instrument unreceipted production firm person, be
Can be by the commercially available conventional products bought and obtain.
The invention provides a kind of moxa-moxibustion cream and preparation method and application, by weight, described moxa-moxibustion cream mainly by
Following material component is made:
Folium Artemisiae Argyi 80～120 parts and Folium Artemisiae Argyi 2～5.5 parts.
This moxa-moxibustion cream is easy to use, is suitable to be widely popularized use.This moxa-moxibustion cream, as external used medicine, avirulence, is made without secondary
With, will not develop immunity to drugs, abundant raw material source, production cost is low, and need not medical knowledge and the Therapeutic Method of complexity
And can use, can be described as the standing medicine of family, also can solve the situation of outlying district shortage of medical services and medicines.
Preferably, moxa-moxibustion cream as above, the preparation method of described Folium Artemisiae Argyi is:
Floss cotton like is crumpled into, through patting to journey thin short flannel shape and get final product after being dried by the fresh Folium Artemisiae Argyi eliminating stem.
The moxa-moxibustion cream that the present invention provides is melted into pulpous state through smashing post-heating when in use.If plaster hardness
Greatly, adhesion strength little, then be affixed on during skin easy to fall off；Cross tender then stickiness too big, lack flexibility, it is impossible to be fixed on that to stick position easy
Mobile, and be difficult to take off.In moxa-moxibustion cream manufacturing process, due to weather, region and boil the factors such as peopleware, Chinese mugwort
Moxibustion cream is crossed the tenderest problem and is difficult to avoid.
For this problem, the present invention preferably adds Apis cerana Fabricius 2～3 parts in its component.
Apis cerana Fabricius is also known as Cera Flava, and it has natural moistureproof resistance to water, emulsibility and slickness.A certain amount of Apis cerana Fabricius can change
Becoming state the tenderest when moxa-moxibustion cream uses, and alleviate the zest to skin to a certain extent, Apis cerana Fabricius Main Ingredients and Appearance is ester
Class, free acid kind, free-fat alcohols and hydro carbons, sweet in the mouth, light, property is put down；Return spleen, stomach, large intestine channel, have removing toxic substances, granulation promoting,
Dysentery relieving, hemostasis, effect of analgesic therapy.It is possible not only to prevent moxa-moxibustion cream from crossing the tenderest problem occurs, moreover it is possible to effectively reduce fire
Poison, reduces the zest to skin.
Preferably, moxa-moxibustion cream as above, by weight, its material component also include glycerol or vaseline 0.02～
0.06 part.
Glycerol is organic polyhydric alcohol, and vaseline is mineral oil, and both of which has the effect of skin protection.The two is added moxa-moxibustion cream
In, can make to form one protecting film in skin surface when using this product, make the moisture of skin be difficult to evaporation and scatter and disappear, and its pole
Water insoluble, can be attached to for a long time on skin, therefore there is good moistening effect, be very suitable for dry skin and use.
Preferably, moxa-moxibustion cream as above, by weight, its material component also includes Oleum menthae 0.04～0.15
Part.
Oleum menthae is that the fresh stem and leaf of labiate Herba Menthae or family Herba Menthae is through distillable aromatic oil.Pungent, cool, nontoxic.
There is dispelling wind, effect of heat clearing away.Can be used for skin or mucosa produces refrigerant sense and is not suitable for alleviate, main pain.Control affection due to external wind and heat, head
Conjunctival congestion bitterly, pharyngalgia, toothache, skin pruritus due to wind pathogen.Herba Menthae has extremely strong sterilization antibacterial action, therefore coordinates moxa-moxibustion cream to use and can also prolong
Its shelf-life long.
The preparation method of moxa-moxibustion cream as above, comprises the following steps:
Fresh Folium Artemisiae Argyi is obtained Folium Artemisiae Argyi concentrated juice and Folium Artemisiae Argyi and other raw materials in addition to Folium Artemisiae Argyi and Folium Artemisiae Argyi through decocting, boiling
Component mixes, after cooling molding and get final product.
The preparation method of the moxa-moxibustion cream that the present invention provides is simple and easy, and science is easy, it is simple to produce in batch.
Preferably, preparation method as above, when fresh Folium Artemisiae Argyi is decocted, described fresh Folium Artemisiae Argyi and added water
Weight ratio be 1:(1～3).
It is furthermore preferred that the weight ratio stating fresh Folium Artemisiae Argyi and added water is 1:2.
Preferably, preparation method as above, the weight of described Folium Artemisiae Argyi concentrated juice is described fresh Folium Artemisiae Argyi weight
20%～30%.
It is furthermore preferred that the weight of described Folium Artemisiae Argyi concentrated juice is described fresh Folium Artemisiae Argyi weight 23%～27%；More preferably
, it is 25%.
The moxa-moxibustion cream as above application in the medicine for external use that preparation treatment arthrosis and cold-evil are caused a disease.
Preferably, applying as above, described arthrosis includes cervical spondylosis, scapulohumeral periarthritis, prolapse of lumbar intervertebral disc；
Described cold-evil is caused a disease and is included cold womb, cold syndrome of the stomach.
Embodiment 1
Present embodiments providing a kind of moxa-moxibustion cream and preparation method thereof, its material component includes:
Folium Artemisiae Argyi 80g；
Folium Artemisiae Argyi 2g；
Apis cerana Fabricius 3g；
Glycerol 0.02g；
Oleum menthae 0.04g；
Its preparation method is
1, being decocted by fresh Folium Artemisiae Argyi, wherein the ratio of Folium Artemisiae Argyi and water is 1:1, and the temperature of decoction is not done concrete
Limit；
2, the slag after decocting is removed, and collects the juice after decocting, and this juice is brewed in step 1 Folium Artemisiae Argyi weight used
The 20% of amount；Obtain concentrated juice；
3, fresh Folium Artemisiae Argyi is dried, removes its stem, crumple into floss cotton like, repave on flat board, repeatedly pat with long bamboo chip,
Become thin short flannel shape, obtain Folium Artemisiae Argyi；
Described Folium Artemisiae Argyi is added to mix homogeneously in the concentrated juice of gained in step 2, obtains mixed serum.
4, the mixed serum of gained in step 3 adds Apis cerana Fabricius and the mixture of glycerol, be sufficiently mixed；
5, the product of gained in step 4 adds Oleum menthae, be sufficiently mixed；
6, step 5 products obtained therefrom is sufficiently mixed uniformly, cools down aftershaping, make moxa-moxibustion cream.
Embodiment 2
Present embodiments providing a kind of moxa-moxibustion cream and preparation method thereof, its material component includes:
Folium Artemisiae Argyi 120g；
Folium Artemisiae Argyi 5.5g；
Apis cerana Fabricius 2g；
Vaseline 0.06g；
Oleum menthae 0.15g；
Its preparation method is
1, being decocted by fresh Folium Artemisiae Argyi, wherein the ratio of Folium Artemisiae Argyi and water is 1:3, and the temperature of decoction is not done concrete
Limit；
2, the slag after decocting is removed, and collects the juice after decocting, and this juice is brewed in step 1 Folium Artemisiae Argyi weight used
The 30% of amount；Obtain concentrated juice；
3, fresh Folium Artemisiae Argyi is dried, removes its stem, crumple into floss cotton like, repave on flat board, repeatedly pat with long bamboo chip,
Become thin short flannel shape, obtain Folium Artemisiae Argyi；
Described Folium Artemisiae Argyi is added to mix homogeneously in the concentrated juice of gained in step 2, obtains mixed serum.
4, the mixed serum of gained in step 3 adds Apis cerana Fabricius and the mixture of glycerol, be sufficiently mixed；
5, the product of gained in step 4 adds Oleum menthae, be sufficiently mixed；
6, step 5 products obtained therefrom is sufficiently mixed uniformly, cools down aftershaping, make moxa-moxibustion cream.
Embodiment 3
Present embodiments providing a kind of moxa-moxibustion cream and preparation method thereof, its material component includes:
Folium Artemisiae Argyi 100g；
Folium Artemisiae Argyi 4g；
Apis cerana Fabricius 2.5g；
Glycerol 0.04g；
Oleum menthae 0.1g；
Its preparation method is
1, being decocted by fresh Folium Artemisiae Argyi, wherein the ratio of Folium Artemisiae Argyi and water is 1:2, and the temperature of decoction is not done concrete
Limit；
2, the slag after decocting is removed, and collects the juice after decocting, and this juice is brewed in step 1 Folium Artemisiae Argyi weight used
The 25% of amount；Obtain concentrated juice；
3, fresh Folium Artemisiae Argyi is dried, removes its stem, crumple into floss cotton like, repave on flat board, repeatedly pat with long bamboo chip,
Become thin short flannel shape, obtain Folium Artemisiae Argyi；
Described Folium Artemisiae Argyi is added to mix homogeneously in the concentrated juice of gained in step 2, obtains mixed serum.
4, the mixed serum of gained in step 3 adds Apis cerana Fabricius and the mixture of glycerol, be sufficiently mixed；
5, the product of gained in step 4 adds Oleum menthae, be sufficiently mixed；
6, step 5 products obtained therefrom is sufficiently mixed uniformly, cools down aftershaping, make moxa-moxibustion cream.
Experimental example medicine irritation and scratch test
Study subject: 80 healthy volunteers that applicant calls together.
Comparative example 1 is arranged: on the basis of embodiment 3, and its material component is adjusted to Folium Artemisiae Argyi 100g；Folium Artemisiae Argyi 4g；Glycerol
0.04g；Oleum menthae 0.1g.Other conditions are constant.
Comparative example 2: publication number CN101181330A, the Chinese mugwort that in the patent in publication date on May 21st, 2008, embodiment 4 provides
Leaf oil.
Experimental technique: moxa-moxibustion cream is applied in after smashing post-heating and being melted into pulpous state waist, cervical vertebra, extremities joint or
Both shoulders part, observes clinical manifestation and the change of skin situation sticking position after 40 hours.
Judge index: different according to feedback opinion and subject's anaphylactic reaction symptom, is divided into 0～3 grade.
0 grade: without significant reaction；
1 grade:
Have and slightly itch, and duration was less than 1 hour, take off after cream without other table disease phenomenons；
Without itching symptom, but after taking off cream, there are slight red point, blister；
Above-mentioned both have, but phenomenon is slight.
2 grades:
Having the phenomenon that significantly scratches, duration is more than 1 hour or with slight general malaise sense；
There are obvious blister, erythema situation after taking off cream, have phenomenon of itching；
Take off certain interval of time after cream, at plaster or periphery has obvious erythema, phenomenon of itching.
3 grades:
Having the serious phenomenon that scratches, it is itched unbearably or with obvious general malaise sense；
After taking off cream, a period of time skin has Severe erythema, phenomenon of festering.
Statistical methods for experiment
If the statistical method of this test is by the statistical test of optimal efficiency test, its sample size size estimation required is
About 200 examples.But sample size is only 80 examples now, is significantly smaller than the sample size of needs, so it is credible that this method can not be applied to carry out
The item inspections such as degree, standard error, so total allergy rate of only statistical test, as shown in table 1.
Table 1 plaster allergy rate
As it can be seen from table 1 the moxa-moxibustion cream zest that the application provides is weak, allergy rate declines to a great extent, and side effect is dropped significantly
Low.Its reason is probably Apis cerana Fabricius by low molecule catabolite emulsifying so that allergic medicine must not discharge, and reduces the stimulation to skin
Property.
Arthrosis and cold-evil are caused a disease and are had good effect by the moxa-moxibustion cream that the present invention provides, and concrete concrete clinic is such as
Under:
Clinical example 1:
Lee, man, 41 years old age, cardinal symptom: lumbago companion's right lower extremity radiation fiber crops pain, Western medicine diagnose is prolapse of lumbar intervertebral disc
Disease.MRI reports: L5/6 intervertebral disk hernia (to the left), corresponding sections root compression, surrounding soft tissue's edema.Pain sitting adds
Play, lies up and alleviates, the waist warm aversion to cold of happiness etc..Reinstated from 08 04th, 2011 the embodiment of the present invention 3 provide moxa-moxibustion cream:
Use the technology auxiliary treatments such as acupuncture, traditional Chinese massage again.Being almost recovered by the treatment of 2 weeks, MRI check is shown in that root compression subtracts
Gently, surrounding soft tissue's edema disappears.
Clinical example 2:
Song, female, at 32 years old age, cardinal symptom: cold womb continues more than 2 years, irregular menstruation, lower abdomen is cold, with breathing hard
Weak, insomnia and dreamful sleep, hypomenorrhea, premenstrual lower abdomen have falling inflation sense, menstruation darkish complexion to have clot.At umbilicus hits exactly the most lower 1.5 cun
The moxa-moxibustion cream that the application embodiment of the present invention 2 provides, avoids eating anything raw or cold simultaneously, at ordinary times the foods such as Fructus Jujubae, Semen Juglandis, eye meat of eating more, 3 months
It is greatly improved through all after date symptoms, the eumenorrhea, fully recovers after 6 menstrual cycle.
Although illustrate and describing the present invention with specific embodiment, but it will be appreciated that without departing substantially from the present invention's
May be made that in the case of spirit and scope many other change and amendment.It is, therefore, intended that in the following claims
Including all such changes and modifications belonged in the scope of the invention.
Claims (10)
1. a moxa-moxibustion cream, it is characterised in that by weight, is mainly made up of following material component:
Folium Artemisiae Argyi 80～120 parts and Folium Artemisiae Argyi 2～5.5 parts.
Moxa-moxibustion cream the most according to claim 1, it is characterised in that the preparation method of described Folium Artemisiae Argyi is:
Floss cotton like is crumpled into, through patting to journey thin short flannel shape and get final product after being dried by the fresh Folium Artemisiae Argyi eliminating stem.
Moxa-moxibustion cream the most according to claim 1, it is characterised in that by weight, its material component also include Apis cerana Fabricius 2～
3 parts.
Moxa-moxibustion cream the most according to claim 3, it is characterised in that by weight, its material component also include glycerol or
Vaseline 0.02～0.06 part.
Moxa-moxibustion cream the most according to claim 4, it is characterised in that by weight, its material component also includes Oleum menthae
0.04～0.15 part.
6. the preparation method of the moxa-moxibustion cream described in any one of Claims 1 to 5, it is characterised in that comprise the following steps:
Fresh Folium Artemisiae Argyi is obtained Folium Artemisiae Argyi concentrated juice, with Folium Artemisiae Argyi and other raw material groups in addition to Folium Artemisiae Argyi and Folium Artemisiae Argyi through decocting, boiling
Part mixing, after cooling molding and get final product.
Preparation method the most according to claim 6, it is characterised in that when fresh Folium Artemisiae Argyi is decocted, described fresh Chinese mugwort
Leaf is 1:(1～3 with the weight ratio of added water).
Preparation method the most according to claim 6, it is characterised in that the weight of described Folium Artemisiae Argyi concentrated juice is described fresh
The 20%～30% of Folium Artemisiae Argyi weight.
9. the answering in the medicine for external use that preparation treatment arthrosis and cold-evil are caused a disease of the moxa-moxibustion cream described in any one of Claims 1 to 5
With.
Application the most according to claim 9, it is characterised in that described arthrosis includes cervical spondylosis, scapulohumeral periarthritis, lumbar intervertebral disc
Prominent；
Described cold-evil is caused a disease and is included cold womb, cold syndrome of the stomach.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610708042.XA CN106214718A (en) | 2016-08-23 | 2016-08-23 | A kind of moxa-moxibustion cream and its preparation method and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610708042.XA CN106214718A (en) | 2016-08-23 | 2016-08-23 | A kind of moxa-moxibustion cream and its preparation method and application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106214718A true CN106214718A (en) | 2016-12-14 |
Family
ID=57553467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610708042.XA Pending CN106214718A (en) | 2016-08-23 | 2016-08-23 | A kind of moxa-moxibustion cream and its preparation method and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106214718A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108815030A (en) * | 2018-06-29 | 2018-11-16 | 孙碧强 | A kind of moxa-moxibustion cream and preparation method thereof |
| CN109602855A (en) * | 2019-01-28 | 2019-04-12 | 河南博善健康管理股份有限公司 | A kind of moxa Tibetan medicinal composition and its production technology |
| CN110464779A (en) * | 2018-05-12 | 2019-11-19 | 程勇 | It is a kind of can preventing and treating diseases moxa-moxibustion mud ointment and preparation method thereof |
| CN111110769A (en) * | 2020-01-21 | 2020-05-08 | 蜜拓蜜大健康管理有限公司 | Preparation method of analgesic moxibustion |
| CN111773299A (en) * | 2020-07-28 | 2020-10-16 | 郑州仙佑医药科技有限公司 | Formula and preparation method of thermal moxibustion ointment |
| CN113925774A (en) * | 2021-11-12 | 2022-01-14 | 吴学刚 | Preparation method of Chinese herbal medicine |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1212878A (en) * | 1997-09-26 | 1999-04-07 | 罗庆道 | Moxibustion liquid --moxibustion fixing paste and its preparation method and use method |
| CN1249181A (en) * | 1998-09-25 | 2000-04-05 | 向虎模 | Universal medicinal cream and its preparing process |
| CN1255372A (en) * | 1999-11-30 | 2000-06-07 | 徐增乐 | Moxiburning ointment and its preparing process and application |
| CN1647806A (en) * | 2004-11-03 | 2005-08-03 | 郎需才 | Leadless plaster medium for Chinese medicine and preparing method |
-
2016
- 2016-08-23 CN CN201610708042.XA patent/CN106214718A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1212878A (en) * | 1997-09-26 | 1999-04-07 | 罗庆道 | Moxibustion liquid --moxibustion fixing paste and its preparation method and use method |
| CN1249181A (en) * | 1998-09-25 | 2000-04-05 | 向虎模 | Universal medicinal cream and its preparing process |
| CN1255372A (en) * | 1999-11-30 | 2000-06-07 | 徐增乐 | Moxiburning ointment and its preparing process and application |
| CN1647806A (en) * | 2004-11-03 | 2005-08-03 | 郎需才 | Leadless plaster medium for Chinese medicine and preparing method |
Non-Patent Citations (2)
| Title |
|---|
| 无: "李万⼭婴⼉艾叶维肤膏 天然植物精华安全放心", 《火爆孕婴童招商网》 * |
| 无: "艾灸膏艾灸法宝艾灸前专用 温灸膏艾叶灸膏通经活络升阳", 《中国供应商》 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110464779A (en) * | 2018-05-12 | 2019-11-19 | 程勇 | It is a kind of can preventing and treating diseases moxa-moxibustion mud ointment and preparation method thereof |
| CN108815030A (en) * | 2018-06-29 | 2018-11-16 | 孙碧强 | A kind of moxa-moxibustion cream and preparation method thereof |
| CN109602855A (en) * | 2019-01-28 | 2019-04-12 | 河南博善健康管理股份有限公司 | A kind of moxa Tibetan medicinal composition and its production technology |
| CN111110769A (en) * | 2020-01-21 | 2020-05-08 | 蜜拓蜜大健康管理有限公司 | Preparation method of analgesic moxibustion |
| CN111773299A (en) * | 2020-07-28 | 2020-10-16 | 郑州仙佑医药科技有限公司 | Formula and preparation method of thermal moxibustion ointment |
| CN113925774A (en) * | 2021-11-12 | 2022-01-14 | 吴学刚 | Preparation method of Chinese herbal medicine |
| CN113925774B (en) * | 2021-11-12 | 2024-01-05 | 吴学刚 | Preparation method of Chinese herbal medicine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106214718A (en) | A kind of moxa-moxibustion cream and its preparation method and application | |
| CN104353019A (en) | Traditional Chinese medicine hot compress bag with meridian dredging and internal organ conditioning functions and preparation method of traditional Chinese medicine hot compress bag | |
| CN102078527A (en) | Traditional Chinese medicine formula for treating urinary calculus | |
| CN103463580B (en) | Chinese medicine ointment for treating pain of muscles, bones and joints and preparation method thereof | |
| CN103735934B (en) | A kind of medicine for the treatment of flank pain and preparation method thereof | |
| CN108635557A (en) | A kind of traditional Chinese medicine foot-bath powder and preparation method thereof | |
| CN102698085A (en) | Chinese medicinal plaster for treating arthritis | |
| CN102579920A (en) | Chinese medicine ointment for curing human-body scars and preparation method thereof | |
| CN102805834B (en) | Drug for curing gastritis and preparation method thereof | |
| CN102389469B (en) | Foot bathing health care medicament | |
| CN104127831A (en) | Traditional Chinese medicine for treating pantalgia after childbirth caused by exogenous pathogen and preparation method thereof | |
| CN104740564B (en) | Treat the Chinese medicine package of postpartum uterine contraction pain | |
| CN102416049B (en) | Small square type rheumatoid swelling diminishing and pain eliminating plaster and preparation method thereof | |
| CN102872420B (en) | Medicine for treating rheumatic arthritis and preparation method thereof | |
| CN102671180B (en) | Medicine for treating rheumatic lumbago and preparation method thereof | |
| CN102961633B (en) | A kind of preparation for being used to treat postpartum rheumatism | |
| CN104971286A (en) | Traditional Chinese medicine composition for treating shoulder, waist and leg discomfort | |
| CN105031380A (en) | Drug for oral local anesthesia of pregnant woman and preparation method thereof | |
| CN104147580A (en) | Moxa for treating hyperostosis | |
| CN105250933B (en) | A kind of preparation method of the 36-flavor Glutinous Chinese medicine composition to activate blood circulation and disperse blood clots and its paste | |
| CN104771732B (en) | A kind of Chinese medicine composition for treating allergic asthma | |
| CN106138628A (en) | A kind of strong medicine ZHICHUANG GAO and preparation method thereof | |
| CN106039257A (en) | Traditional Chinese medicine mud-moxibustion ointment and preparation method thereof | |
| CN105641226A (en) | Hot-compress salt for treating dysmenorrhea and preparation method | |
| CN104189195B (en) | The Traditional Chinese medicine medicated bath for the treatment of neurotic skin pruritus and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161214 |
|
| RJ01 | Rejection of invention patent application after publication |